News

Posted On: 04/11/2007

Ortho-McNeil Recalls Glass-Tainted Product

PharmaManufacturing.com

Ortho-McNeil and the U.S. Food & Drug Administration (FDA) on Apr. 10 informed healthcare professionals and consumers of a nationwide recall of griseofulvin oral suspension, a prescription medication used to treat ringworm and other fungal infections. The recall was issued based on two reports of glass fragments found in bottles of the liquid formulation.

The recall is limited to the liquid formulation of the medication and does not include any other dosage form. Consumers in possession of the medication should contact the pharmacy where they purchased the drug to determine if they have the product that has been recalled and direct medical questions to their healthcare professional.

The FDA distributed this information through MedWatch, its safety information and adverse event reporting program.